Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients-Reference-Cited by-同舟云学术

Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients

Published:2020-07-29 Issue:7 Volume:4 Page:1101-1113
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Chan Anthony K.¹^ORCID,Alamelu Jayanthi²,Barnes Chris³,Chuansumrit Ampaiwan⁴^ORCID,Garly May‐Lill⁵,Meldgaard Rikke Medom⁵,Young Guy⁶^ORCID

Affiliation:

1. McMaster Children’s Hospital/McMaster University Hamilton ON Canada

2. Evelina London Children’s Hospital London UK

3. The Royal Children’s Hospital Melbourne VIC Australia

4. Ramathibodi HospitalMahidol University Bangkok Thailand

5. Novo Nordisk A/S Søborg Denmark

6. Children’s Hospital Los AngelesUniversity of Southern California Keck School of Medicine Los Angeles CA USA

Funder

Novo Nordisk A/S

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12412

Reference42 articles.

1. Haemophilia B: current pharmacotherapy and future directions

2. Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?

3. World Federation of Hemophilia.Guidelines for the management of hemophilia. 2012. [Accessed July 22 2019.] Available fromhttp://www1.wfh.org/publications/files/pdf‐1472.pdf

4. New developments in the treatment of pediatric hemophilia and bleeding disorders

5. Barriers to primary prophylaxis in haemophilic children: the issue of the venous access;Santagostino E;Blood Transfus,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of nonacog beta pegol during surgery in persons with hemophilia B: a case series;Research and Practice in Thrombosis and Haemostasis;2023-10

2. Current factor IX replacement options for hemophilia B and the challenges ahead;Expert Opinion on Pharmacotherapy;2023-03-29

3. Considerations for shared decision management in previously untreated patients with hemophilia A or B;Therapeutic Advances in Hematology;2023-01

4. Hemophilia B: Diagnosis and Management;Congenital Bleeding Disorders;2023

5. The More Recent History of Hemophilia Treatment;Seminars in Thrombosis and Hemostasis;2022-09-15